1. Home
  2. CAE vs LEGN Comparison

CAE vs LEGN Comparison

Compare CAE & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CAE Inc.

CAE

CAE Inc.

HOLD

Current Price

$29.71

Market Cap

8.5B

Sector

N/A

ML Signal

HOLD

Logo Legend Biotech Corporation

LEGN

Legend Biotech Corporation

HOLD

Current Price

$22.33

Market Cap

5.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CAE
LEGN
Founded
1947
2014
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.5B
5.9B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
CAE
LEGN
Price
$29.71
$22.33
Analyst Decision
Buy
Strong Buy
Analyst Count
4
13
Target Price
$33.75
$69.67
AVG Volume (30 Days)
570.3K
2.5M
Earning Date
11-11-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.97
N/A
Revenue
$3,470,482,234.00
$909,045,000.00
Revenue This Year
$6.40
$68.83
Revenue Next Year
$5.69
$51.27
P/E Ratio
$30.62
N/A
Revenue Growth
9.12
74.75
52 Week Low
$20.36
$22.28
52 Week High
$30.13
$45.30

Technical Indicators

Market Signals
Indicator
CAE
LEGN
Relative Strength Index (RSI) 76.89 21.96
Support Level $27.07 $26.43
Resistance Level $28.58 $28.97
Average True Range (ATR) 0.65 1.57
MACD 0.35 -0.43
Stochastic Oscillator 99.41 0.91

Price Performance

Historical Comparison
CAE
LEGN

About CAE CAE Inc.

CAE Inc provides training and aviation services, integrated enterprise solutions, in-service support, and crew-sourcing services. The company operations are managed through two segments: Civil Aviation which offers comprehensive training solutions for flight, cabin, maintenance, and ground personnel in commercial, business, and helicopter aviation, a complete range of flight simulation training devices, ab initio pilot training, and crew sourcing services, as well as aircraft flight operations solutions; and Defense and Security which is a world-wide training and simulation provider delivering scalable, platform-independent solutions that enable and enhance force readiness and security. It generates the majority of its revenue from the Civil Aviation segment.

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Share on Social Networks: